Honeywell International (HON) PT Raised to $230 at Jefferies Seeing $11 in '23 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts HON Hot Sheet
Rating Summary:
19 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Join SI Premium – FREE
Jefferies analyst Sheila Kahyaoglu raised the price target on Honeywell International (NASDAQ: HON) to $230.00 (from $225.00) on new '21 EPS of $8.05, up from from $7.90 reflecting the Q2 beat and HBT/PMT recovery.
The analyst reiterated a Hold rating, stating "2021 EPS advances 13% on a 6% rev increase. HON trades at ~18x 2022 EV/EBITDA, or a 26% premium to mkt (vs a 16% historical premium), capturing the pace of improvement. The opportunity is EPS upside from new products (70c) and cap deployment, w/ potential for '23 EPS of $11.00 assuming 100% of cash deployed".
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $465 at Cantor Fitzgerald
- Amgen (AMGN) PT Raised to $400 at Bernstein SocGen Group
- Amgen (AMGN) PT Raised to $470 at RBC Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
